Assignee
BIOSCEPTRE AUST PTY LTD
AU·12 granted patents·8 pending applications·20 citations·filing 2016–2024
Top patents by PatentIndex Score
20 records- 0189US12097265B2Cytotoxic particles for targeting P2X7 receptorBIOSCEPTRE AUST PTY LTD·Filed 2022·Granted Sep 24, 2024·1 cites·19 claims
- 0289US2025084161A1Anti p2x7 receptor antibodies and fragments thereofBIOSCEPTRE AUST PTY LTD·Filed 2024·Application pending·0 cites
- 0388US10053508B2Anti P2X7 receptor antibodies and fragments thereofBIOSCEPTRE AUST PTY LTD·Filed 2017·Granted Aug 21, 2018·5 cites·15 claims
- 0487US10988532B2Anti P2X7 receptor antibodies and fragments thereofBIOSCEPTRE AUST PTY LTD·Filed 2018·Granted Apr 27, 2021·2 cites·16 claims
- 0585US11260131B2Cytotoxic particles for targeting P2X7 receptorBIOSCEPTRE AUST PTY LTD·Filed 2017·Granted Mar 1, 2022·2 cites·14 claims
- 0685US10245308B2Combination therapy utilizing P2X7 peptidesBIOSCEPTRE AUST PTY LTD·Filed 2017·Granted Apr 2, 2019·4 cites·9 claims
- 0783US10238716B2Anti-P2X7 peptides and epitopesBIOSCEPTRE AUST PTY LTD·Filed 2016·Granted Mar 26, 2019·3 cites·3 claims
- 0883US10232025B2Method for minimising progression of cancer in companion animalsBIOSCEPTRE AUST PTY LTD·Filed 2016·Granted Mar 19, 2019·3 cites·10 claims
- 0976US12129295B2Anti P2X7 receptor antibodies and fragments thereofBIOSCEPTRE AUST PTY LTD·Filed 2021·Granted Oct 29, 2024·0 cites·16 claims
- 1072US2020071419A1Antibodies to non-functional p2x7 receptorBIOSCEPTRE AUST PTY LTD·Filed 2019·Application pending·0 cites
- 1170US2024368282A1Methods and compositions for stimulating immune activityBIOSCEPTRE AUST PTY LTD·Filed 2022·Application pending·0 cites
- 1267US10450380B2Polypeptide immunogen for generating an antibody to non-functional P2X7 receptorBIOSCEPTRE AUST PTY LTD·Filed 2017·Granted Oct 22, 2019·0 cites·7 claims
- 1365US2026085104A1Methods of detecting immune cellsBIOSCEPTRE AUST PTY LTD·Filed 2023·Application pending·0 cites
- 1464US10597451B2Methods of treating cancer with a P2X7 peptideBIOSCEPTRE AUST PTY LTD·Filed 2018·Granted Mar 24, 2020·0 cites·12 claims
- 1564US2025101080A1Chimeric antigen receptors and uses thereofBIOSCEPTRE AUST PTY LTD·Filed 2024·Application pending·0 cites
- 1662US10543262B2Combination therapy utilizing P2X7 peptidesBIOSCEPTRE AUST PTY LTD·Filed 2019·Granted Jan 28, 2020·0 cites·9 claims
- 1760US2025282844A1Methods for controlling immune cell activityBIOSCEPTRE AUST PTY LTD·Filed 2022·Application pending·0 cites
- 1860US2025281611A1Novel cell therapy systemBIOSCEPTRE AUST PTY LTD·Filed 2022·Application pending·0 cites
- 1943US12121539B2Chimeric antigen receptors and uses thereofBIOSCEPTRE AUST PTY LTD·Filed 2016·Granted Oct 22, 2024·0 cites·29 claims
- 2033US2022251187A1P2x7 receptor targeted therapyBIOSCEPTRE AUST PTY LTD·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →